The coming of age for CDK 4/6 inhibitors: Understanding new treatment options for mBC patients
| Event title | Event dates | Event venue | Website of the event | Main speciality | Name of the CME provider | Amount of ECMEC® credits |
|---|---|---|---|---|---|---|
| The coming of age for CDK 4/6 inhibitors: Understanding new treatment options for mBC patients | 05/05/2017 - 05/05/2017 | Belgium, Brussels | Website | Breast Care | ecancer / Cancer Intelligence Ltd | 0.0 European CME credits (ECMEC®) |
